Protective Effects of Panax Notoginseng Saponins on Cardiovascular Diseases: A Comprehensive Overview of Experimental Studies
Open Access
- 1 January 2014
- journal article
- review article
- Published by Hindawi Limited in Evidence-Based Complementary and Alternative Medicine
- Vol. 2014, 1-13
- https://doi.org/10.1155/2014/204840
Abstract
Panax notoginseng saponins (PNS) are one of the most important compounds derived from roots of the herb Panax notoginseng which are traditionally used as a hemostatic medicine to control internal and external bleeding in China for thousands of years. To date, at least twenty saponins were identified and some of them including notoginsenoside R1, ginsenoside Rb1, and ginsenoside Rg1 were researched frequently in the area of cardiovascular protection. However, the protective effects of PNS on cardiovascular diseases based on experimental studies and its underlying mechanisms have not been reviewed systematically. This paper reviewed the pharmacology of PNS and its monomers Rb1, Rg1, and R1 in the treatment for cardiovascular diseases.Keywords
Funding Information
- National Basic Research Program of China (2003CB517103, 90209011)
This publication has 80 references indexed in Scilit:
- Chinese herbal formulas for treating hypertension in traditional Chinese medicine: perspective of modern scienceHypertension Research, 2013
- Trends in the Treatment of Hypertension from the Perspective of Traditional Chinese MedicineEvidence-Based Complementary and Alternative Medicine, 2013
- Chinese Herbal Medicine Qi Ju Di Huang Wan for the Treatment of Essential Hypertension: A Systematic Review of Randomized Controlled TrialsEvidence-Based Complementary and Alternative Medicine, 2013
- Chinese Patent Medicine Liu Wei Di Huang Wan Combined with Antihypertensive Drugs, a New Integrative Medicine Therapy, for the Treatment of Essential Hypertension: A Systematic Review of Randomized Controlled TrialsEvidence-Based Complementary and Alternative Medicine, 2012
- Current Situation and Perspectives of Clinical Study in Integrative Medicine in ChinaEvidence-Based Complementary and Alternative Medicine, 2012
- Comparative study on saponin fractions from Panax notoginseng inhibiting inflammation-induced endothelial adhesion molecule expression and monocyte adhesionChinese Medicine, 2011
- Ginsenoside-Rg1 mediates a hypoxia-independent upregulation of hypoxia-inducible factor-1α to promote angiogenesisAngiogenesis, 2011
- Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive surveyDrug Design, Development and Therapy, 2011
- Toll-like receptor ligand-induced activation of murine DC2.4 cells is attenuated by Panax notoginsengJournal of Ethnopharmacology, 2008
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsThe New England Journal of Medicine, 1998